Medical treatment of brain tumours, particularly glioma, with an emphasis on novel drug evaluation for glioblastoma
Warren P Mason
Oculoleptomeningeal amyloidosis secondary to the rare Transthyretin c.381T>G (p.Ile127Met) mutation.
World Neurosurg. 2017 Dec 22;:
Curr Oncol. 2017 Dec;24(6):374-382
Can J Neurol Sci. 2017 Dec 18;:1-7
CNS Oncol. 2017 Dec 15;:
Can J Neurol Sci. 2017 Nov 20;:1-6
Neuro Oncol. 2017 Sep 01;:
Hepatology. 2017 Sep 06;:
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
Lancet. 2017 Aug 08;:
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.
Neuro Oncol. 2017 Jun 09;:
N Engl J Med. 2017 06 01;376(22):2197
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Associate Professor, Department of Medicine, University of Toronto
Medical Director, Gerry and Nancy Pencer Brain Tumour Centre
Kirchmann Family Chair in Neurooncology Research, Princess Margaret Hospital